Valbiotis S.A.
ALVAL.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €175 | €4,733 | €785 | €298 |
| % Growth | -96.3% | 502.9% | 163.4% | – |
| Cost of Goods Sold | €2,618 | €2,044 | €18 | €16 |
| Gross Profit | -€2,443 | €2,689 | €767 | €282 |
| % Margin | -1,396% | 56.8% | 97.7% | 94.6% |
| R&D Expenses | €4,332 | €7,150 | €9,102 | €7,028 |
| G&A Expenses | €3,732 | €2,161 | €688 | €360 |
| SG&A Expenses | €8,092 | €4,177 | €1,502 | €1,219 |
| Sales & Mktg Exp. | €4,360 | €2,016 | €814 | €859 |
| Other Operating Expenses | -€4,444 | -€1,458 | €2,189 | €510 |
| Operating Expenses | €7,980 | €9,869 | €12,793 | €8,757 |
| Operating Income | -€10,423 | -€7,160 | -€14,055 | -€10,871 |
| % Margin | -5,956% | -151.3% | -1,790.4% | -3,648% |
| Other Income/Exp. Net | €432 | -€2,236 | -€149 | €440 |
| Pre-Tax Income | -€9,991 | -€9,396 | -€14,204 | -€10,431 |
| Tax Expense | €34 | -€2,028 | -€1,892 | -€1,750 |
| Net Income | -€10,025 | -€7,368 | -€12,312 | -€8,681 |
| % Margin | -5,728.6% | -155.7% | -1,568.4% | -2,913.1% |
| EPS | -0.63 | -0.59 | -1.22 | -0.95 |
| % Growth | -6.8% | 51.6% | -28.4% | – |
| EPS Diluted | -0.63 | -0.59 | -1.22 | -0.95 |
| Weighted Avg Shares Out | 15,794 | 12,462 | 10,115 | 9,158 |
| Weighted Avg Shares Out Dil | 15,794 | 12,462 | 10,115 | 9,158 |
| Supplemental Information | – | – | – | – |
| Interest Income | €662 | €33 | €0 | €0 |
| Interest Expense | €230 | €221 | €287 | €348 |
| Depreciation & Amortization | €587 | €736 | €852 | €941 |
| EBITDA | -€9,172 | -€6,411 | -€11,134 | -€9,142 |
| % Margin | -5,241.1% | -135.5% | -1,418.3% | -3,067.8% |